On Tuesday, Moderna Inc (NASDAQ: MRNA) opened lower -2.59% from the last session, before settling in for the closing price of $34.71. Price fluctuations for MRNA have ranged from $29.25 to $170.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 662.63% over the last five years. Company’s average yearly earnings per share was noted -8.81% at the time writing. With a float of $341.66 million, this company’s outstanding shares have now reached $386.00 million.
The firm has a total of 5800 workers. Let’s measure their productivity. In terms of profitability, gross margin is 52.28%, operating margin of -122.17%, and the pretax margin is -111.71%.
Moderna Inc (MRNA) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Moderna Inc is 11.44%, while institutional ownership is 70.79%. The most recent insider transaction that took place on Mar 03 ’25, was worth 5,004,318. In this transaction Chief Executive Officer of this company bought 160,314 shares at a rate of $31.22, taking the stock ownership to the 9,210,686 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Director bought 31,620 for $31.76, making the entire transaction worth $1,004,251. This insider now owns 312,027 shares in total.
Moderna Inc (MRNA) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -3.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -8.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.68% during the next five years compared to -42.94% drop over the previous five years of trading.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Check out the current performance indicators for Moderna Inc (MRNA). In the past quarter, the stock posted a quick ratio of 3.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -9.28, a number that is poised to hit -3.09 in the next quarter and is forecasted to reach -7.82 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Analysing the last 5-days average volume posted by the [Moderna Inc, MRNA], we can find that recorded value of 7.29 million was lower than the volume posted last year of 12.16 million. As of the previous 9 days, the stock’s Stochastic %D was 44.81%. Additionally, its Average True Range was 2.49.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 16.03%, which indicates a significant decrease from 50.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 81.64% in the past 14 days, which was higher than the 76.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $35.95, while its 200-day Moving Average is $68.64. Now, the first resistance to watch is $34.69. This is followed by the second major resistance level at $35.58. The third major resistance level sits at $36.15. If the price goes on to break the first support level at $33.23, it is likely to go to the next support level at $32.66. Now, if the price goes above the second support level, the third support stands at $31.77.
Moderna Inc (NASDAQ: MRNA) Key Stats
There are currently 385,816K shares outstanding in the company with a market cap of 13.04 billion. Presently, the company’s annual sales total 3,236 M according to its annual income of -3,561 M. Last quarter, the company’s sales amounted to 966,000 K and its income totaled -1,120 M.
